222 related articles for article (PubMed ID: 23919839)
21. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore.
Png ME; Yoong JS
PLoS One; 2014; 9(9):e107225. PubMed ID: 25203633
[TBL] [Abstract][Full Text] [Related]
23. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes.
Roberts S; Barry E; Craig D; Airoldi M; Bevan G; Greenhalgh T
BMJ Open; 2017 Nov; 7(11):e017184. PubMed ID: 29146638
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of the Da Qing diabetes prevention program: A modelling study.
Hu W; Xu W; Si L; Wang C; Jiang Q; Wang L; Cutler H
PLoS One; 2020; 15(12):e0242962. PubMed ID: 33382746
[TBL] [Abstract][Full Text] [Related]
25. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
Pan XR; Li GW; Hu YH; Wang JX; Yang WY; An ZX; Hu ZX; Lin J; Xiao JZ; Cao HB; Liu PA; Jiang XG; Jiang YY; Wang JP; Zheng H; Zhang H; Bennett PH; Howard BV
Diabetes Care; 1997 Apr; 20(4):537-44. PubMed ID: 9096977
[TBL] [Abstract][Full Text] [Related]
26. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
Hemmingsen B; Gimenez-Perez G; Mauricio D; Roqué I Figuls M; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003054. PubMed ID: 29205264
[TBL] [Abstract][Full Text] [Related]
27. Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany.
Schaufler TM; Wolff M
Appl Health Econ Health Policy; 2010; 8(3):191-202. PubMed ID: 20408603
[TBL] [Abstract][Full Text] [Related]
28. SLIMMER: a randomised controlled trial of diabetes prevention in Dutch primary health care: design and methods for process, effect, and economic evaluation.
Duijzer G; Haveman-Nies A; Jansen SC; ter Beek J; Hiddink GJ; Feskens EJ
BMC Public Health; 2014 Jun; 14():602. PubMed ID: 24928217
[TBL] [Abstract][Full Text] [Related]
29. A review of the economic evidence for acarbose in the prevention of diabetes and cardiovascular events in individuals with impaired glucose tolerance.
Josse RG; McGuire AJ; Saal GB
Int J Clin Pract; 2006 Jul; 60(7):847-55. PubMed ID: 16858756
[TBL] [Abstract][Full Text] [Related]
30. Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions.
Dalziel K; Segal L
Health Promot Int; 2007 Dec; 22(4):271-83. PubMed ID: 17916604
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study.
Palmer JL; Goodall G; Nielsen S; Kotchie RW; Valentine WJ; Palmer AJ; Roze S
Curr Med Res Opin; 2008 May; 24(5):1417-28. PubMed ID: 18400145
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of a Stepwise Approach vs Standard Care for Diabetes Prevention in India.
Islek D; Weber MB; Ranjit Mohan A; Mohan V; Staimez LR; Harish R; Narayan KMV; Laxy M; Ali MK
JAMA Netw Open; 2020 Jul; 3(7):e207539. PubMed ID: 32725244
[TBL] [Abstract][Full Text] [Related]
33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
34. Value of lifestyle intervention to prevent diabetes and sequelae.
Dall TM; Storm MV; Semilla AP; Wintfeld N; O'Grady M; Narayan KM
Am J Prev Med; 2015 Mar; 48(3):271-80. PubMed ID: 25498548
[TBL] [Abstract][Full Text] [Related]
35. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis.
Kahn R; Alperin P; Eddy D; Borch-Johnsen K; Buse J; Feigelman J; Gregg E; Holman RR; Kirkman MS; Stern M; Tuomilehto J; Wareham NJ
Lancet; 2010 Apr; 375(9723):1365-74. PubMed ID: 20356621
[TBL] [Abstract][Full Text] [Related]
36. Review of models used in economic analyses of new oral treatments for type 2 diabetes mellitus.
Asche CV; Hippler SE; Eurich DT
Pharmacoeconomics; 2014 Jan; 32(1):15-27. PubMed ID: 24357160
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland.
Brändle M; Azoulay M; Greiner RA
Int J Clin Pharmacol Ther; 2007 Apr; 45(4):203-20. PubMed ID: 17474539
[TBL] [Abstract][Full Text] [Related]
38. Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.
Liu J; Mozaffarian D; Sy S; Lee Y; Wilde PE; Abrahams-Gessel S; Gaziano T; Micha R;
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006313. PubMed ID: 32493057
[TBL] [Abstract][Full Text] [Related]
39. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).
Ramachandran A; Snehalatha C; Mary S; Mukesh B; Bhaskar AD; Vijay V;
Diabetologia; 2006 Feb; 49(2):289-97. PubMed ID: 16391903
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes.
Ackermann RT; Marrero DG; Hicks KA; Hoerger TJ; Sorensen S; Zhang P; Engelgau MM; Ratner RE; Herman WH
Diabetes Care; 2006 Jun; 29(6):1237-41. PubMed ID: 16732002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
